Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

<18>F-labeled fluoropyridylformylglycine, and preparation method and application thereof

A technology of fluoropicolinoylglycine and picolinoylglycine, which is applied in the field of fluoropicolinoylglycine and its preparation, can solve the problems of long time, cumbersome synthesis steps, inability to obtain high-quality kidney images and the like, and achieves excellent stability, good biological performance

Active Publication Date: 2019-09-06
FIRST HOSPITAL OF SHANXI MEDICAL UNIV
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

but 99m Tc-MAG3 with 131 I-OIH is similar in terms of renal imaging, unable to obtain high-quality renal images
Therefore, compared with PET / CT, the above SPECT techniques using corresponding imaging drugs are incomparable in terms of imaging quality and precise quantitative analysis.
Based on the above reasons, many experts and scholars at home and abroad are committed to developing a new type of imaging agent with biological properties suitable for renal PET / CT scanning, in order to replace the shortcomings of traditional imaging equipment and imaging agents for kidney imaging. then 15 O-H 2 O. 13 N-NH 3 , 82 Rb-Rb 1 , 62 CuCu(II)pyruvaldehydebis-(N-4-methylthiosemicarbazonato), 62 Cu-Cu(II)ethylglyoxal bis(thiosemicarbazone), 68 Ga-Ga-ethylenediaminetetraacetic acid, 55 Co-Co-ethylenediamine tetraacetic acid and 18 Positron imaging agents such as F-NaF have been applied one after another, but due to the short half-life or high cost of these imaging agents, they have not been really used clinically to serve patients.
In recent years, Vibhudutta Awasthi et al. have developed a new kidney imaging agent p- 18 F-fluorohippurate ( 18 F-PFH), this imaging agent has ideal biological characteristics, it is almost excreted by the urinary system, and 131 Compared with I-OIH, it shows a higher kidney / background ratio, and does not go through the metabolism of the liver and biliary system, and the uptake of other tissues and organs except the kidney is relatively low, and the imaging effect of the kidney is quite ideal, but 18 F-PFH synthesis steps are cumbersome and take a long time, resulting in a decline in yield
Based on the above research results, Vibhudutta Awasthi et al. have developed another imaging agent with similar structure 18 F-CNPFH, compared to 18 The synthesis steps of F-PFH are relatively simple, but due to the metabolism of the imaging agent in the liver and biliary system, the background around the kidney is relatively high, and the imaging effect is not very ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • &lt;18&gt;F-labeled fluoropyridylformylglycine, and preparation method and application thereof
  • &lt;18&gt;F-labeled fluoropyridylformylglycine, and preparation method and application thereof
  • &lt;18&gt;F-labeled fluoropyridylformylglycine, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0027]The present invention also provides a kind of described in above-mentioned technical solution 18 The preparation method of the fluoropicolinylglycine of F mark, comprises the steps:

[0028] (1) bromopicolinylglycinate, solvent and [ 18 F] - The source is mixed, the nucleophilic reaction is carried out, and after purification, the 18 F-fluoropicolinyl glycinate; the [ 18 F] - source contains [ 18 F] - And catalyst; The bromopicolyl glycinate is 6-bromo-3-pyridineformyl glycinate, 5-bromo-2-pyridineformyl glycinate or 4-bromo-2-pyridineformyl glycinate;

[0029] (2) the above 18 F-fluoropicolinylglycinate is mixed with sodium hydroxide solution for hydrolysis reaction, then passed through an acidic ion exchange column, and then filtered through a sterile filter membrane to obtain 18 F-labeled fluoropicolinylglycine.

[0030] The raw materials used in the preparation method provided by the invention are easy to obtain, and the obtained 18 F-labeled fluoropicoliny...

Embodiment 1

[0075] 6-bromo-3-pyridinecarboxylic acid (1.00g, 4.95mmol), N,N-dicyclohexylcarbodiimide (1.22g, 5.94mmol), 4-dimethylaminopyridine (0.36g, 2.97mmol) and Anhydrous dichloromethane (20 mL) was mixed, stirred evenly in an ice-water bath (0° C.), and reacted for 30 minutes to obtain a reaction solution containing activated 6-bromo-3-pyridinecarboxylic acid;

[0076] Triethylamine (0.82mL, 5.94mmol), glycine methyl ester hydrochloride (0.75g, 5.94mmol) and anhydrous dichloromethane (15mL) were mixed and added dropwise to the activated 6-bromo-3-pyridine In the reaction solution of formic acid, after the dropwise addition, return to room temperature (23°C), continue to stir the reaction for 20h, TLC detects that the reaction is complete, then filter, and the obtained filtrate is subjected to vacuum rotary evaporation, and then the 300-400 mesh silica gel column is used as The chromatographic column is subjected to column chromatography, and the eluent used in the column chromatogra...

Embodiment 2

[0084] According to the method of Example 1, the raw material 6-bromo-3-pyridinecarboxylic acid was replaced by 5-bromo-2-pyridinecarboxylic acid to prepare 5-[ 18 F]-fluoro-2-pyridinecarbonylglycine.

[0085] According to the method test of embodiment 1 5-[ 18 The radiochemical yield after correction of F]-fluoro-2-pyridineformylglycine was 10±3%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to View More

Abstract

The invention provides an <18>F-labeled fluoropyridylformylglycine, and a preparation method and an application thereof, and belongs to the technical field of radioactive medicinal chemistry. The <18>F-labeled fluoropyridylformylglycine is 6-[<18>F]-fluoro-3-pyridylformylglycine, 5-[<18>F]-fluoro-2-pyridylformylglycine or 4-[<18>F]-fluoro-2-pyridylformylglycine. The <18>F-labeled fluoropyridylformylglycine provided by the invention has an excellent stability and good biological properties, and has no adverse effects on organisms after decaying. Results of in-vivo distribution test show that the <18>F-labeled fluoropyridylformylglycine is mainly taken in by the kidney and immediately excreted, and the <18>F-labeled fluoropyridylformylglycine is almost completely discharged into the bladder10 min after being injected into a mouse, so the <18>F-labeled fluoropyridylformylglycine is particularly advantageous for the renal function evaluation of renal lesions.

Description

technical field [0001] The invention relates to the technical field of radiopharmaceutical chemistry, in particular to a 18 F-labeled fluoropicolilylglycine, its preparation method and application. Background technique [0002] Positron emission tomography (PET) technology is an important means of diagnosing diseases based on the molecular level. Due to its good spatial resolution and quantitative analysis advantages, it has been widely used and affirmed in clinical and scientific research. However, at present, the equipment for imaging the urinary system in the field of nuclear medicine still stays on SPECT, and the main imaging agent is still 99m Tc-DTPA and 99m Tc-MAG3. 99m Since Tc-DTPA is almost completely excreted from the plasma through the glomerulus, its main function is to determine the glomerular filtration rate (GFR) clinically. However, due to the limitations of SPECT imaging equipment, the clinical determination of GFR is not very accurate. Part of the reas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D213/82C07D213/81C07B59/00A61K51/04A61K101/02
CPCC07D213/82C07D213/81C07B59/002A61K51/0455C07B2200/05
Inventor 王红亮武志芳李思进董伟璇赵琦南
Owner FIRST HOSPITAL OF SHANXI MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products